US Food and Drug Administration gets it right

BMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7367.776 (Published 05 October 2002) Cite this as: BMJ 2002;325:776
  1. Matthew L Grove, consultant rheumatologist (Matthew.Grove@northumbria-healthcare.nhs.uk)
  1. North Tyneside General Hospital, North Shields, NE29 8NH

    EDITOR—With reference to the news item by Burke,1 the withholding of data provided by manufacturers for the use of the National Institute for Clinical Excellence (NICE) in reaching its decisions is in marked contrast to the policy followed by the Food and Drug Administration (FDA) in America.

    I have recently …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial